Literature DB >> 21295903

Variability in the performing of spirometry and its consequences in the treatment of COPD in primary care.

Mònica Monteagudo1, Teresa Rodriguez-Blanco, Judith Parcet, Núria Peñalver, Carles Rubio, Montserrat Ferrer, Marc Miravitlles.   

Abstract

BACKGROUND: Several studies have approached the use of spirometry in the treatment of chronic obstructive pulmonary disease (COPD) in Primary Care (PC), but few have analysed its impact on the treatment of the patient with COPD.
OBJECTIVES: To evaluate the use of spirometry in the diagnosis and follow-up of COPD patients in PC, and its impact on treatment. To analyse the variation in the performing of spirometry between PC centres.
METHODOLOGY: A multicentre, observational and cross-sectional study of COPD patients seen in PC in Catalonia (Spain) during 2004-2005. A multilevel logistic regression model was used to identify factors associated with having spirometry and to determine the variation between the different centres.
RESULTS: Twenty-one centres which included 801 patients took part. Only 53.2% of them had a diagnostic spirometer available and the mean (standard deviation) FEV1(%) was 54.8% (18%). The registers of smoking habits, complementary tests and spirometry follow-up were more common among patients who had a diagnostic spirometry available compared to those who did not. No statistically significant differences were found as regards demographic, clinical, treatment and quality of life variables between patients with and without follow-up spirometry. Significant variation was observed in the percentage of diagnostic spirometries between different PC centres (variance=0.217; p<0.001).
CONCLUSION: Spirometry is underused in PC and performing it during follow-up is not associated to the different treatments received, or with a more complete approach to the disease. There is significant variation in the performing of spirometry among PC centres.
Copyright © 2010 SEPAR. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21295903     DOI: 10.1016/j.arbres.2010.10.009

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  11 in total

1.  Difficulties in differential diagnosis of COPD and asthma in primary care.

Authors:  Marc Miravitlles; Isabel Andreu; Yolanda Romero; Salvador Sitjar; Andreu Altés; Esther Anton
Journal:  Br J Gen Pract       Date:  2012-02       Impact factor: 5.386

2.  Differences in the use of spirometry between rural and urban primary care centers in Spain.

Authors:  Eduardo Márquez-Martín; Joan B Soriano; Myriam Calle Rubio; Jose Luis Lopez-Campos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-08-17

3.  Characteristics of COPD patients initiating treatment with aclidinium or tiotropium in primary care in Catalonia: a population-based study.

Authors:  Mònica Monteagudo; Montse Roset; Teresa Rodriguez-Blanco; Laura Muñoz; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2017-04-12

4.  Improvement in the management of chronic obstructive pulmonary disease following a clinical educational program: results from a prospective cohort study in the Sicilian general practice setting.

Authors:  Rosarita Ferrara; Valentina Ientile; Carlo Piccinni; Alessandro Pasqua; Serena Pecchioli; Andrea Fontana; Umberto Alecci; Riccardo Scoglio; Francesco Magliozzo; Sebastiano Emanuele Torrisi; Carlo Vancheri; Patrizio Vitulo; Giovanna Fantaci; Carmen Ferrajolo; Mario Cazzola; Claudio Cricelli; Achille Patrizio Caputi; Gianluca Trifirò
Journal:  NPJ Prim Care Respir Med       Date:  2018-03-23       Impact factor: 2.871

5.  Population-based study of LAMA monotherapy effectiveness compared with LABA/LAMA as initial treatment for COPD in primary care.

Authors:  Miriam Barrecheguren; Mónica Monteagudo; Marc Miravitlles
Journal:  NPJ Prim Care Respir Med       Date:  2018-09-28       Impact factor: 2.871

6.  [Accesibility and use of spirometry in primary care centers in Catalonia].

Authors:  M Antònia Llauger; Alba Rosas; Felip Burgos; Elena Torrente; Ricard Tresserras; Joan Escarrabill
Journal:  Aten Primaria       Date:  2014-04-24       Impact factor: 1.137

7.  Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD.

Authors:  Mònica Monteagudo; Miriam Barrecheguren; Iryna Solntseva; Nafeesa Dhalwani; Alison Booth; Alexa Nuñez; Dimitra Lambrelli; Marc Miravitlles
Journal:  NPJ Prim Care Respir Med       Date:  2021-03-22       Impact factor: 2.871

8.  Economic Impact of Low Adherence to COPD Management Guidelines in Spain.

Authors:  Marc Miravitlles; Alexandra Solé; Helena Aguilar; Ana Ampudia; Jaume Costa-Samarra; Maria Mallén-Alberdi; Diana Nieves
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-11-16

9.  The clinical and economic impact of exacerbations of chronic obstructive pulmonary disease: a cohort of hospitalized patients.

Authors:  Francesco Blasi; Giancarlo Cesana; Sara Conti; Virginio Chiodini; Stefano Aliberti; Carla Fornari; Lorenzo Giovanni Mantovani
Journal:  PLoS One       Date:  2014-06-27       Impact factor: 3.240

Review 10.  [Alveolar epithelial cell injury as an etiopathogenic factor in pulmonary fibrosis].

Authors:  Anna Serrano-Mollar
Journal:  Arch Bronconeumol       Date:  2012-10       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.